Skip to content
The Policy VaultThe Policy Vault

V-Go deviceMedical Mutual

Continuous insulin infusion therapy for diabetes mellitus (type 1 or insulin dependent type 2)

Initial criteria

  • Patient age ≥ 18 years; AND
  • Patient requires continuous subcutaneous infusion of either 20 Units, 30 Units, or 40 Units of basal insulin in a 24-hour time period AND on-demand dosing of up to 36 Units of bolus insulin in a 24-hour time period; AND
  • Patient must be using a rapid-acting insulin product (U-100 only) in the device; AND
  • Patient has been using multiple doses of insulin injections a day (3 injections daily or more); AND
  • Patient has worked with a provider to adjust dose of insulin for at least 6 months and failed to meet glucose goals; AND
  • Patient does not need to make regular adjustments or modifications to their basal rate during a 24-hour period, OR patient’s amount of bolus insulin used does not require adjustments of less than 2 unit increments; AND
  • Patient meets ONE of the following while on insulin: HbA1c > 7%; OR history of recurring hypoglycemia; OR wide fluctuations in blood glucose before mealtime; OR dawn phenomenon with fasting blood sugars frequently exceeding 200 mg/dL; OR history of severe glycemic excursions; AND
  • Patient has tried and failed an external insulin pump (failure such as: blood glucose control cannot be maintained on an external pump OR member has barriers that cannot allow the use of an external pump) [documentation required]; AND
  • Patient’s total daily insulin requirement does not exceed 76 units.

Reauthorization criteria

  • Patient age ≥ 18 years; AND
  • Patient requires continuous subcutaneous infusion of either 20 Units, 30 Units, or 40 Units of basal insulin in a 24-hour time period AND on-demand dosing of up to 36 Units of bolus insulin in a 24-hour time period; AND
  • Patient is using a rapid-acting insulin product (U-100 only) in the device; AND
  • Patient’s total daily insulin requirement does not exceed 76 units; AND
  • Patient is currently on the V-Go device OR member has tried and failed an external insulin pump (failure such as: blood glucose control cannot be maintained on an external pump OR member has barriers that cannot allow the use of an external pump) [documentation required].

Approval duration

1 year initial, 1 year reauth